SG Americas Securities LLC increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST – Get Rating) by 16.2% in the first quarter, Holdings Channel reports. The company held 7,059 shares of the medical device supplier’s stock after purchasing an additional 982 shares during the period. SG Americas Securities LLC’s holdings in West Pharmaceutical Services were worth $2,899,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of WST. Kestra Advisory Services LLC increased its position in West Pharmaceutical Services by 9.2% during the fourth quarter. Kestra Advisory Services LLC now owns 2,905 shares of the medical device supplier worth $1,363,000 after acquiring 244 additional shares in the last quarter. Strs Ohio increased its position in West Pharmaceutical Services by 120.4% during the fourth quarter. Strs Ohio now owns 9,943 shares of the medical device supplier worth $4,663,000 after acquiring 5,432 additional shares in the last quarter. National Bank of Canada FI acquired a new position in West Pharmaceutical Services during the fourth quarter worth approximately $10,889,000. Signaturefd LLC increased its position in West Pharmaceutical Services by 33.9% during the fourth quarter. Signaturefd LLC now owns 817 shares of the medical device supplier worth $383,000 after acquiring 207 additional shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its position in West Pharmaceutical Services by 63.3% during the fourth quarter. Tokio Marine Asset Management Co.Ltd. now owns 2,023 shares of the medical device supplier worth $949,000 after acquiring an additional 784 shares in the last quarter. 93.25% of the shares are currently held by institutional investors and hedge funds.
West Pharmaceutical Services Share Performance
NYSE: WST opened at $313.64 on Friday. The company has a debt ratio of 0.09, a current ratio of 2.89 and a quick ratio of 2.18. The company has a market capitalization of $23.23 billion, a price/earnings ratio of 34.85, a PEG ratio of 3.14 and a beta of 1.13. The company’s 50-day moving average is $302.61 and its two-hundred-day moving average is $351.59. West Pharmaceutical Services, Inc. has a 1-year low of $275.89 and a 1-year high of $475.35.
West Pharmaceutical Services (NYSE:WST – Get Rating) last released its results on Thursday, April 28. The medical device supplier reported earnings per share of $2.30 for the quarter, beating the consensus estimate of $2.18 by $0.12. The company posted revenue of $720.00 million for the quarter, versus analyst estimates of $720.92 million. West Pharmaceutical Services achieved a net margin of 23.76% and a return on equity of 30.33%. West Pharmaceutical Services revenue increased 7.4% year-over-year. During the same period a year earlier, the company posted EPS of $2.05. Analysts expect West Pharmaceutical Services, Inc. to post EPS of 9.3 for the current year.
West Pharmaceutical Services Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 3. Shareholders of record on Wednesday, July 20 will receive a dividend of $0.18. The ex-dividend date is Tuesday, July 19. This represents an annualized dividend of $0.72 and a yield of 0.23%. West Pharmaceutical Services payout rate is 8.00%.
Analysts set new price targets
Separately, StockNews.com downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a Thursday, April 28 research report.
About West Pharmaceutical Services
(Get an evaluation)
West Pharmaceutical Services, Inc. designs, manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, Middle East, Africa and Asia-Pacific. It operates in two segments, Proprietary Products and Contract Manufactured Products.
Want to see which other hedge funds hold WSTs? Visit HoldingsChannel.com for the latest 13F filings and insider trading for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
Get daily news and reviews for West Pharmaceutical Services – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for West Pharmaceutical Services and related companies with MarketBeat.com’s free daily email newsletter.